Company profile: CC Bio
1.1 - Company Overview
Company description
- Provider of microbiome-focused therapeutic discovery for diagnosis and treatment. Products include Zeus, a platform to evaluate and optimize therapeutics for precise augmentation of microbial ecology; Athena, a platform developing genetic components for biosensor circuits that sense microbiome diseases; and Dionysus, a program engineering bacterial chassis to sense metabolic changes and record information across human tissues.
Products and services
- Athena: A modular discovery platform that architects genetic components for biosensor circuits, enabling precise sensing of microbiome-based diseases through engineered constructs integrated into biosensor assemblies
- Dionysus: A custom-engineered program that engineers bacterial chassis to sense metabolic changes and record information across different human tissue systems, constructing chassis configured for reliable detection and information capture
- Zeus: A proprietary drug discovery platform that evaluates and optimizes potential therapeutics for precise augmentation of microbial ecology, producing candidates prioritized for efficacy in microbiome modulation
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CC Bio
Helmer Scientific
HQ: United States
Website
- Description: Provider of specialized medical and laboratory equipment, including GX Solutions medical-grade refrigerators and freezers for critical healthcare applications with temperature control, noise management, and energy efficiency; Pro Line platelet incubators with performance monitoring and advanced cooling; i.Series ultra-low temperature freezers; i.Series laboratory refrigerators/freezers; and blood bank refrigerators.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Helmer Scientific company profile →
Akadeum Life Sciences
HQ: United States
Website
- Description: Provider of bioseparation products that facilitate the removal of target cells from biological samples.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Akadeum Life Sciences company profile →
Biopremier
HQ: Portugal
Website
- Description: Provider of molecular biology products and DNA sequencing services for the Agrifood, Environmental, Human Clinical, and Animal Health industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biopremier company profile →
Nanosphere
HQ: United States
Website
- Description: Provider of a nanotechnology-based molecular diagnostics platform and clinical tests for genomic and protein testing and analysis. Instruments use microfluidics to pull DNA and proteins, delivering results in hours rather than days or weeks, with sensitivity two to three times higher than common hospital lab tests and much simpler.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanosphere company profile →
HighRes Biosolutions
HQ: United States
Website
- Description: Provider of modular laboratory automation systems and software for pharmaceutical, biotech, and academic research labs. Designs and builds innovative robotic systems and devices, including Nucleus hardware, Cellario integration software, MicroDock & MicroCart, CoLAB Flex collaborative robots, automated sample storage, and ancillary devices. Founded in 2004, headquartered in Woburn, Massachusetts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HighRes Biosolutions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CC Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CC Bio
2.2 - Growth funds investing in similar companies to CC Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CC Bio
4.2 - Public trading comparable groups for CC Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →